Summary A panel of eight human pancreatic tumour cell lines displayed high intrinsic radioresistance, with mean inactivation doses between 2.4 and 6.5 Gy, similar to those reported for melanoma and glioblastoma. The radiosensitising potency of sodium nitroprusside, a bioreductive nitric oxide donor, was assessed in a model of metabolism-induced hypoxia in a cell micropellet. Sodium nitroprusside at 0.1 mm revealed a radiosensitising effect with an overall enhancement ratio of 1.9 compared with 2.5 for oxygen. Radiosensitising activity correlated with the enhancement of single-strand DNA breakage caused by radiation. In suspensions with cell densities of between 3% and 30% (v/v), the half-life of sodium nitroprusside decreased from 31 to 3.2 min, suggesting a value of around min for micropellets. Despite this variation, the radiosensitising activity was similar in micropellets and in diluted cell suspensions. S-nitroso-L-glutathione was found to possess radiosensitising activity, consistent with a possible role of natural thiols in the storing of radiobiologically active nitric oxide adducts derived from sodium nitroprusside. As measured by a nitric oxide-specific microsensor, activation of sodium nitroprusside occurred by bioreduction, whereas S-nitroso-L-glutathione showed substantial spontaneous decomposition. Both agents appear to exert radiosensitising action through nitric oxide as its scavenging by carboxy phenyltetramethylimidazolineoxyl N-oxide (carboxy-PTIO) and oxyhaemoglobin resulted in attenuated radiosensitisation. Sodium nitroprusside was at least 10-fold more potent than etanidazole, a 2-nitroimidazole used as a reference. Our data suggest that sodium nitroprusside, a drug currently used for the treatment of hypertension, is a potential tumour radioresponse modifier.
Adenocarcinoma of the pancreas is the fourth leading cause of cancer-related deaths and represents a type of tumour refractory to radiotherapy (Brennan et al., 1993) . The poor response rates to external beam radiotherapy may be explained by the proximity of many dose-limiting organs and possibly by intrinsic and hypoxia-induced radioresistance as well. The latter factor is of considerable interest, because hypoxic cells can be specifically targeted by electron-affinic compounds such as nitroimidazoles and bioreductive cytotoxins (Adams, 1992) .
Nitric oxide (NO) is a relatively long-life radical generated endogenously by nitric oxide synthases, and has been implicated in signal transduction in the nervous and vascular system and as a cytotoxin in pathophysiological processes related to cellular immunity and hypoxia -reoxygenation injury (Knowles and Moncada, 1994) . NO, in gaseous form or released chemically from the NONOate complex DEA/ NO, has also been shown to radiosensitise hypoxic cells. The mechanism of NO-mediated radiosensitisation has been postulated to be the fixation of radiation-induced DNA damage, thus mimicking the effects of oxygen on DNA lesions (Howard-Flanders, 1957; Mitchell et al., 1993) .
In the present study we investigated the radiosensitivity of established human pancreatic tumour cell lines with a range of growth rates and differentiation grades. The radiobiological parameters of pancreatic tumour cells have not yet been extensively analysed. Another objective was to explore the radiosensitising potency and DNA-targeting properties of sodium nitroprusside (SNP), containing NO in the form of nitrosonium cation coordinated to the ironcyanide complex. SNP is a clinically used vasodilator with a well-known pharmacology and toxicity. Whereas NONOates release NO spontaneously in aqueous media (Maragos et al., 1991 (Maragos et al., , 1993 , SNP is activated by a one-electron transfer reduction (Bates et al., 1991) . This reaction may be catalysed by thiols with an optimum pH of 6 -7, common for metabolism-induced hypoxia in solid tumours. Therefore, we examined the radiosensitising activity of SNP using a metabolism-mediated hypoxia model. We also analysed the rate of SNP bioactivation at different cell densities and explored the role of NO using a specific microsensor and the scavengers 2-(4-carboxyphenyl)-4,4,5,5-tetramethyllimidazolene-l-oxyl-3-oxide (carboxy-PTIO) and oxyhaemoglobin. Another NO donor investigated here was S-nitroso-Lglutathione (GSNO). This agent represents the major product of NO interaction with intracellular thiols (Clancy et al., 1994) and thus may be involved in metabolic pathways of the nitrosonium cation derived from SNP. The chemical agents generating NO after reductive bioactivation can be regarded as a novel class of hypoxic tumour cell radiosensitisers.
Materials and methods Chemicals
A818-7 were 21, 23, 23, 25, 32, 29, 32 and 45 h respectively. The last four cell lines display the highest degree of morphological and immunocytochemical differentiation (Maillet et al., 1993) . PSN1/ADR is a multidrug-resistant subline established in our laboratory from PSN1 by selection in 170 nM doxorubicin (Verovski et al., 1996) . The adherent cultures were maintained in RPMI 1640 medium (Gibco, Paisley, UK) supplemented with 10% bovine calf serum (HyClone Laboratories, Logan, UT, USA) at 37°C in 5% carbon dioxide/95% air. All in vitro experiments were carried out on plastic tissue culture plates (Greiner, Frickenhausen, Germany).
Radiation
Cultures grown to early confluence were trypsinised, and the cells were washed by centrifugation in medium and counted. All steps in sample preparation and processing were performed at 0°C, unless otherwise stated. Cells were irradiated at 37°C at a dose rate of 2 Gy min-' using an 8 MV photon beam from a linear accelerator and immediately cooled.
Intrinsic radiosensitivity was assessed under aerobic conditions in a suspension containing 2 x 105 cells ml-'. Cell survival was estimated by both colony formation and MTT serial dilution assay. Hypoxic cell radiosensitivity was estimated in cell suspensions and in cell micropellets. The hypoxia in micropellets was achieved by metabolic oxygen depletion using the following procedure. Cells (5 x 105) in 200 ,ul of medium were transferred into 200 ,ul plastic micropipetter tips closed at the end by flame. Radiosensitisers at indicated concentrations were added during the preparation of cell suspensions. The tips were placed in sterile plastic tubes, which were used as holders. The tubes contained 0.5 ml of water to ensure heat conductivity. Afterwards cells were centrifuged at 300 g for 5 min, resulting in the formation of a micropellet at the end of the tips. Generally, cell pellets were incubated for 10 min at 37°C before irradiation to induce metabolic oxygen depletion. After irradiation, the supernatant from cell pellets was aspirated and the cells were resuspended in medium (1 ml) using a 1 ml syringe with a 21 gauge needle. Cell survival fractions were further determined by a MTT serial dilution assay and the data were fitted to survival curves according to the linear-quadratic model. Hypoxia in a cell suspension (2.5-10 x 106 ml-1) was used to compare the molar radiosensitising potency SNP, GSNO and etanidazole, and to estimate the radioprotective activity of the NO scavengers carboxy-PTIO and oxyhaemoglobin. In these experiments, hypoxia was achieved by repeated vacuum evacuation/injection (both 30 s) of 5% carbon dioxide/95% nitrogen for 20 min. Hypoxic cells in suspension were incubated for 10 min at 37°C, irradiated and processed as described above.
MTT serial dilution assay The MTT assay measures the number of metabolically active cells by quantification of their ability to reduce MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) to water-insoluble formazan crystals. To assess cell survival after irradiation we used a MTT assay adapted for radiobiological experiments by Carmichael et al. (1987) , which we modified as follows. Cells were seeded into 96-well plates at eight serial dilutions using a 0.5 log dilution factor and a starting inoculum of 32 x 103 cells per well (dilution= 1). This allowed the useful range of the assay to be extended up to 3 logs of cell kill. Routinely, serial dilutions from control and irradiated samples were produced directly in the plates by sequential mixing 93 ,ul of cell suspension with 200 ,ul of medium prefilled in plates. Cultures were allowed to grow for five cell-doubling times. To prepare for the MTT assay, the plates were emptied of medium by quick decantation and drying on filter paper. The assay was Hypoxic cell radiosensitisation by sodium nitroprusside VN Figure 1 . Finally, the dilutions of the control (C) and treated (T) samples were determined at the level of 10% absorbency and the survival fractions for all treated samples were calculated at T/C. The same protocol was used to estimate the direct cytotoxicity of SNP. Bioactivation of sodium nitroprusside Bioactivation of SNP was monitored by the accumulated cyanide using a methaemoglobin-based spectroscopic assay (Smith and Kruszana, 1974) . PSN1/ADR cells (10-100 x 106 cells ml-') were incubated in the presence of 0.1 mM SNP and 0.1 mM methaemoglobin at 37°C with constant shaking. At the indicated time points the reaction was stopped by a 30-fold dilution with cold phosphatebuffered saline (PBS). Afterwards, samples were centrifuged for 2 min at 500 g and the cyanide -methaemoglobin complex in the supernatant was quantified by an increase in absorbency at 425 nM. A calibration curve was obtained with dilutions of sodium cyanide in the range 0.01 -0.1 mM.
The radioprotective effect of nitric oxide scavengers PSN1/ADR cells (10 x 106 cells ml-') were incubated in the presence of 0.1 mM SNP and 1 mM GSNO under conditions of hypoxia induced by 5% carbon dioxide/95% nitrogen as described above. When used, the scavengers carboxy-PTIO and oxyhaemoglobin were added to produce final concentrations of 1 and 0.1 mM respectively. After 10 min preincubation at 37°C cell suspensions were irradiated at 8 Gy and analysed for cell survival by the MTT serial dilution assay. Figure 1 for the cell line PSN1/ADR. Radiation-survival curves for the other eight human pancreatic tumour cell lines are shown in Figure 2 . The range of intrinsic radiosensitivity was considerable, and SF2 varied from 0.46 (PSN1) up to 0.75 (Panc-1). Of interest is the observation that selection of PSN1/ADR cells for doxorubicin resistance resulted in enhanced radiosensitivity compared with the parental PSN1 cells (Figures 1 and 2 ). This cell line was used further to study the radiosensitising effects and pharmacology of SNP but was not involved in correlation analysis because of its artificial origin. In this study we have used also an alternative approach to characterise the initial parts of survival curves using the model-free parameter MID introduced by Fertil and Malaise (1985) . The MID values in normoxia for PSN1, PT45, Mia Paca 2, PaTu 2, HPAF, Panc-1, Colo 357 and A818-7 were 2.4, 2.9, 3.1, 3.6, 3.8, 4.0, 4.6 and 6.5 Gy respectively. Human pancreatic tumour cells possess high intrinsic radioresistance similar to that reported for melanomas and glioblastomas by these authors (2.1-2.7 and 1.6-4.6 Gy respectively). The correlation coefficient (R) of MID and SF2 was 0.76. MID and SF2 values correlated with the doubling times (R = 0.98 and R=0.70 respectively).
We also re-evaluated the aerobic radiosensitivity using a colony formation assay (Figure 2 Comparison of radiosensitising potency ofsodium nitroprusside, S-nitroso-L-glutathione and etanidazole The radiosensitising potency of SNP, GSNO and etanidazole, used as a reference, was compared in PSN1 cells at 8 Gy. Hypoxic cells in suspension rather than in a pellet were used to control more accurately the extracellular concentration of the agent. All three agents exerted a distinct radiosensitising effect at non-cytotoxic concentrations, with SNP being approximately 10-fold more potent than the others (Figure 3) . The high radiosensitising potency of SNP was the rationale for extended radiobiological and pharmacological studies.
Hypoxic cell radioresponse and radiosensitising potency of sodium nitroprusside in a panel of human pancreatic tumour cell lines Hypoxic cell radiosensitivity and radiosensitising effects of SNP in human pancreatic tumour cell lines are summarised in Figure 4 and analysed in more detail for the cell lines Hypoxic cell radiosensitisadon by sodium nitroprusside VN Verovski et a! 7 1737 Panc-I and PSN1/ADR in Table I . To access hypoxic cell radiosensitivity, we used a model of metabolic hypoxia in a micropellet of cells (0.5 x 106) in plastic pipette tips. Preliminary experiments showed that hypoxic radioprotection could be obtained within 5 min of incubation at 37°C and that cell viability was not affected during an additional incubation up to 15 min. Although a limited diffusion of oxygen through the plastic walls may be present, we found no difference in hypoxic cell radioprotection between plastic tips and conical glass tubes (data not shown). As shown for normoxia in Table I , the oxygen enhancement ratios (OERs) were increased at lower survival fractions. At a survival fraction of 0.1 the OER was 2.7-2.9, close to that observed by Mitchell et al. (1993) for a dense cell suspension in sealed syringes, hence confirming the presence of deep hypoxia in the pellet. The mean MID value for a panel of human tumour pancreatic cells was 9.6 (6.6-12.9) Gy in hypoxia compared with 3.9 (2.4-6.5) Gy for oxic cells, giving an overall OER of 2.5+0.29 (Figure 4 ). aMID, mean inactivation dose, was measured under the specified conditions. bThe enhancement ratios were calculated from the linear-quadratic fits at the survival fractions of 0.75, 0.32, and 0.1 in normoxia. Sodium nitroprusside (SNP) was slightly cytotoxic at 1-3.2 mm, therefore the survival curves and radiosensitisation effects have been corrected for direct cytotoxicity.
To study the radiosensitising effects of SNP, this compound was added to the cell suspensions before formation of pellets by centrifugation. The radiosensitising activity of SNP remained stable when the incubation time of the pellets at 37°C during the induction of hypoxia varied between 5 and 20 min. A concentration-dependent radiosensitising effect was found in the range of 0.01-0.3 mM (Table I) . In contrast to oxygen, SNP showed a higher radiosensitising effect at survival fractions of 0.32-0.75 than at 0.1, corresponding to radiation doses of 2-4 and 8-12 Gy respectively. Under aerobic conditions, SNP did not sensitise cells to radiation.
The radiosensitising potency of SNP was further evaluated in a panel of eight cell lines (Figure 4) . SNP at 0.1 mm was a potent hypoxic cell radiosensitiser with a mean enhancement ratio of 1.9 and an overall efficiency of 76% compared with oxygen. In the most radioresistant cell lines (A818-7, Colo-357, Panc-I and HPAF), we observed a reduced radiosensitising effect that could be improved by increasing the SNP concentration up to 0.3 mM (shown in Table I for Panc-1).
Bioactivation rate of sodium nitroprusside It is known that in the presence of cells or reducing agents SNP {Na2[(CN)5FeNO]} undergoes reductive activation resulting in the generation of NO, CN and cyanoferrate (Bates et al., 1991) . The production rate of NO is difficult to measure in a dense cell suspension because of the fast reaction of this radical with multiple cellular and extracellular targets. Therefore, we preferred to measure the CN ion, which is a stable metabolite and can be quantitatively detected by a spectroscopic methaemoglobin assay. The accumulation rate of SNP-derived CN was measured at 37°C in the range 10-100 x 106 cells ml-', corresponding to 3-30% (v/v) of the cell density in the pellet (Figure 5) . At a maximal cell density only one of five molecules of CN was released from SNP even at prolonged incubation times of up to 32 min. As the release of the first molecule of CN is immediately followed by the generation of NO (Bates et al., 1991) , an equimolar production of CN and NO is expected. At 3 -30% cell density, the half-life of SNP linearly decreased from 31 to 3.2 min, suggesting a value of around 1 min in the case of a micropellet. This would imply complete decomposition of SNP in pellets at the time of irradiation. In the absence of cells no CN release was detected (data not shown). The effect of NO scavengers on the radiosensitising activity of sodium nitroprusside and S-nitroso-L-glutathione SNP may exert radiosensitisation through either NO or CN as detailed in the 'Discussion'. We tested the radiosensitising activity of sodium cyanide at a concentration corresponding to complete decomposition of SNP, resulting in the release of one molecule of CN. Sodium cyanide caused radiosensitisation, but could account only for 17% of the effect of SNP in suspensions ( Figure 6 ) and 40% in pellets (data not shown). However, regarding the half-life of 31 min in suspensions (Figure 5 ), the real concentration of SNP-derived CN at the time of irradiation should not exceed 0.02 mM and CN alone could cause only marginal radiosensitisation. Therefore, we attempted to explore the role of NO using oxyhaemoglobin, a well-characterised scavenger of NO, and carboxy-PTIO, a specific NO oxidiser (Akaike et al., 1993) . The radiosensitising activity of GSNO (1 mM) in a suspension of PSN1 cells (10 x 106 cells ml-') was substantially attenuated by both scavengers, and oxyhaemoglobin was found to abrogate completely the radiosensitising action ( Figure 6 ). In the case of SNP (0.1 mM), the radioprotective efficiency of NO scavengers was lower but remained significant. Amperometric measurement of NO generated by sodium nitroprusside and S-nitroso-L-glutathione As NO scavengers demonstrated diminished efficiency in abrogating SNP-mediated radiosensitisation (see above), we studied in more detail the mechanism of NO release using a NO-specific microsensor. This sensor measures only free radical NO that can be directly released from NO donors in extracellular space or appears there because of diffusion from the intracellular NO pool. SNP generated NO almost exclusively by a bioreductive mechanism (Figure 7) , and the low background of spontaneous NO release was probably a result of its known photosensitivity (Bates et al., 1991) . The addition of carboxy-PTIO resulted in complete scavenging of the NO signal in contrast to an only partial radioprotective effect ( Figure 6 ). GSNO revealed a substantial background of spontaneous NO release and, strikingly, the total signal of extracellular NO exceeded that of SNP by 2.9-fold.
The effect of sodium nitroprusside on radiation-induced DNA breakage NO is believed to radiosensitise hypoxic cells by a mechanism of DNA damage fixation similar to oxygen (Mitchell et al., 1993) . However, no experimental support for this hypothesis exists at present. Therefore, we examined the radiosensitising effects of SNP in relation to DNA breakage in a wide concentration range of 0.01-3 mM (Figure 8 ). These effects have been corrected for the direct cytotoxicity of SNP apparent at 1-3 mm. Hypoxic PSN1 cells irradiated at 8 Gy showed a reduced frequency of single-strand DNA breaks that may be attributed to the mechanism of hypoxic cell radioprotection. Hypoxic cell radiosensitisation by 0.01-0.3 mM SNP was paralleled by an increasing level of DNA breakage approaching that observed in oxic cells. The upper concentrations of SNP were cytotoxic and caused DNA damage but did not further enhance radiosensitivity or DNA breakage. It is noteworthy that the radiosensitising potency of SNP in pellets (Figure 8 ) and in diluted cell suspensions (Figures 3 and 6 ) was similar.
Discussion
Our analysis of radiation responses in a panel of eight human pancreatic tumour cell lines suggests that both intrinsic and hypoxia-induced radioresistance may contribute to failure of Figure 7 Amperometric measurement of NO generated by sodium nitroprusside and S-nitroso-L-glutathione. The release of NO from sodium nitroprusside (a) and S-nitroso-L-glutathione (b) was estimated by a Iso-NOP200 microsensor at 37°C, under a 5% nitrogen-5% carbon dioxide atmosphere. The spontaneous and bioreductive release of NO was measured respectively in the absence (0) and presence (A) of PSN1/ADR cells (32 x 106cells ml-1). The NO scavenger carboxy-PTIO (PTIO) was added after 6 min incubation (closed symbols) to produce a final concentration of 1 mM.
local control in pancreatic cancer. To analyse cellular radioresistance we preferred to use the model-free parameter MID introduced by Fertil and Malaise (1985) rather than SF2. The enhancement ratios of radiosensitisers cannot be calculated directly from SF2 data. Furthermore, SF2 in hypoxic cells is frequently higher than 0.8 and therefore difficult to measure accurately. As determined by the MTT serial dilution assay, all cell lines possessed a high level of intrinsic radioresistance, in terms of MID values (2.4-6.5 Gy), similar to those reported by Fertil and Malaise (1985) for melanomas (2.1-2.7 Gy) and glioblastomas (1.6-4.6 Gy). This conclusion was confirmed by a colony formation assay, although the mean MID was 23% lower (1.6-4.9 Gy). Possibly, the short-term MTT assay overestimates cell survival after irradiation because non-clonogenic cells may remain metabolically active. To evaluate the radiosensitising activity of bioreductive radiosensitisers, we modified a model of metabolism-induced hypoxia previously described by Mitchell et al. (1993) . We used a cell micropellet in plastic tips rather than a dense cell suspension as this approach requires 10-30 times fewer cells and fewer technical precautions to prevent reoxygenation. At a survival fraction of 0.1, OER was 2.7-2.9, indicating radiobiologically relevant hypoxia, as also observed in the model of Mitchell et al. (1993) . SNP, a well-known bioreductive NO donor (Bates et al., 1991) , has been found to be an efficient radiosensitiser of hypoxic cells at non-cytotoxic concentrations between 0.01 and 0.3 mM. In a panel of eight lines, SNP at 0.1 mM showed a mean enhancement ratio of 1.9 compared with 2.5 for oxygen. The molar radiosensitising potency of SNP was at least 10-fold higher than that of etanidazole, a representative of 2-nitroimidazoles undergoing clinical trials. Interestingly, at survival fractions above 0.3, which are attributed to clinically relevant doses of radiation (2-4 Gy), SNP demonstrated an increased radiosensitising effect, whereas oxygen showed a reduced effect. This phenomenon resembles the recent findings on etanidazole and buthionine sulphoximine, whose radiosensitising effects, in contrast to oxygen, were increased at high survival fractions MacPhail, 1992, 1994 In contrast to SNP, GSNO spontaneously liberated NO into the medium and generated higher extracellular concentrations of NO by bioreduction. This increased pool of extracellular NO was contradictory to the lower radiosensitising activity, which again confirms the lack of correlation between NO production and radiosensitising activity for bioreductive NO donors. Endogenously formed GSNO is conceivably the major adduct of natural thiols, with nitrosonium cation accumulated in cells after exposure to NO (Ignarro et al., 1981; Stamler et al., 1992; Clancy et al., 1994) . As such, it may also be involved in the trapping and storing of SNP-derived NO adducts in hypoxic cells, thereby supporting delayed radiosensitisation. On the other hand, increased levels of intracellular glutathione may slow down the transfer of the SNP-derived NO towards DNA as a result of trapping of the nitrosonium cation, and sustain intrinsic radioresistance at the same time (Skov and MacPhail, 1992) . This could be one of the mechanisms underlying a decreased radiosensitising effect of SNP in the more radioresistant cell lines A818-7, Colo-357, Panc-I and HPAF. Hence, the radiosensitising potency of SNP can be reduced in slowgrowing and well-differentiated tumour cells possessing elevated radioresistance.
Recently, the NONOate complex DEA/NO has been proposed as a hypoxic tumour cell radiosensitiser with a dual action on both tumour and vascular cells (Mitchell et al., 1993) . The authors speculated that, besides direct sensitisation of hypoxic tumour cells, DEA/NO may improve tumour oxygenation and radiosensitisation because of the vasodilatory effect on tumour vasculature. However, the reduction in tumour blood flow and oxygenation due to preferential peripheral vasodilatation and decrease in blood pressure is also possible. Indeed, these alternative effects have been already described for the vasodilators flunarizine and hydralazine (discussed in Teicher et al., 1993) . Another limitation to the use of NO prodrugs may arise from their side-effects on the nervous systems, which is responsive to low concentrations of NO (Knowles and Moncada, 1994) . Therefore, the concentrations of NO required for radiosensitisation may be difficult to obtain in vivo for any NO donor. The minimum concentration of SNP expected to exert radiosensitisation is close to 0.01 mM. Such a concentration in plasma is achievable at subtoxic doses in mice (Smith and Kruszyna, 1974) , but in humans a safety infusion protocol of SNP used to maintain vasodilatation (<3 ,ug min-' kg-') would not result in a sufficient level of NO equivalents. The same problem applies to DEA/NO, which spontaneously liberates NO with a constant half-life of 2.1 min (Maragos et al., 1993) . In metabolically induced hypoxia, DEA/NO showed half-reversal of radioprotection at 0.3-0.5 mM, whereas SNP reveals the same effect at a concentration of 0.1 mM and at similar or longer half-lives. The comparison of the SNP and DEA/NO potency indicates that bioreductive NO donors may evoke radiosensitising action at reduced pharmacokinetic doses, a feature claimed also for other bioreductive modifiers that exploit redox conditions in hypoxic cells (Adams, 1992) . At present, it is not clear whether redox microenvironments in tumours might favour the accumulation of NO intermediates up to radiobiologically active levels at tolerated doses of SNP. However, the radiosensitising effect of infused SNP combined with carbogen breathing has been clearly observed in Lewis carcinoma-bearing mice (Teicher et al., 1993) , thus warranting further in vivo studies of this promising bioreductive radiosensitiser.
In conclusion, our studies in human pancreatic tumour cell lines have provided a radiobiological rationale for the poor radioresponsiveness in pancreatic cancer based on high intrinsic cellular radioresistance. Additionally, we demonstrated that SNP, a bioreductive NO donor, elicits efficient hypoxic cell radiosensitisation through the generation of NO and fixation of DNA damage. SNP, an active vasodilatory drug with a long history in the treatment of hypertension, may also be of value as a tumour radioresponse modifier.
Abbreviations SNP, sodium nitroprusside; GSNO, S-nitroso-L-glutathione; NO, nitric oxide; DEA/NO, complex of diethylamine with NO; MID, mean inactivation dose; SF2, survival fraction at 2 Gy; OER, oxygen enhancement ratio.
